Furthermore, neutralizing antibodies directed atHMGB-1 rescued mice from lethal endotoxemia even when administered 24 hoursafter sepsis initiation [7, 9].For these reasons, HMGB-1 is viewed as an attractive therapeutic target for various inflammatorydisorders including endotoxic shock [10]. This evidence concerns the gene HMGB1 and Sepsis.